Cargando…

Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent chronic liver disease globally. NAFLD is strongly associated with metabolic syndrome and it has been recently suggested that to rename NAFLD as metabolic dysfunction-associated fatty liver disease (MAFLD). NAFLD has been studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arefhosseini, Sara, Ebrahimi-Mameghani, Mehrangiz, Najafipour, Farzad, Tutunchi, Helda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676462/ https://www.ncbi.nlm.nih.gov/pubmed/36419770 http://dx.doi.org/10.3389/fendo.2022.1032361

Ejemplares similares

Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study
por: Arefhosseini, Sara, et al.
Publicado: (2023)

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
por: Badali, Taghi, et al.
Publicado: (2023)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Effects of Hydroxycitric Acid Supplementation on Body Composition, Obesity Indices, Appetite, Leptin, and Adiponectin of Women with NAFLD on a Calorie-Restricted Diet
por: Tutunchi, Helda, et al.
Publicado: (2023)

The effect of DASH diet on glycemic response, meta-inflammation and serum LPS in obese patients with NAFLD: a double-blind controlled randomized clinical trial
por: Rooholahzadegan, Farnaz, et al.
Publicado: (2023)

What are the optimal cut-off points of anthropometric indices for prediction of overweight and obesity? Predictive validity of waist circumference, waist-to-hip and waist-to-height ratios
por: Tutunchi, Helda, et al.
Publicado: (2020)

Is the modified household food security survey (HFSS) questionnaire a practical tool for screening food insecurity? Evidence from northwest of Iran
por: Tutunchi, Helda, et al.
Publicado: (2020)

Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
por: Song, Myeong Jun, et al.
Publicado: (2022)

What hematological and endocrinal indicators are important in COVID-19 infection?
por: Ostadrahimi, Alireza, et al.
Publicado: (2022)

Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial
por: Ebrahimi-Mameghani, Mehrangiz, et al.
Publicado: (2016)

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
por: Roshanravan, Neda, et al.
Publicado: (2022)

Effect of vitamin D supplementation in combination with weight loss diet on lipid profile and sirtuin 1 in obese subjects with vitamin D deficiency: a double blind randomized clinical trial
por: Aliashrafi, Soodabeh, et al.
Publicado: (2019)

Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
por: Burnett, Deborah L., et al.
Publicado: (2022)

SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population
por: Hua, Xiaomin, et al.
Publicado: (2023)

Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism
por: Ostadrahimi, Alireza, et al.
Publicado: (2023)

Pembrolizumab: An Immunotherapeutic Agent Causing Endocrinopathies
por: Chaudry, Abdul, et al.
Publicado: (2020)

Celiac Disease and the Autoimmune Web of Endocrinopathies
por: Sange, Ibrahim, et al.
Publicado: (2020)

Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial
por: Tutunchi, Helda, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
por: Della Torre, Sara
Publicado: (2020)

Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial
por: Akbari, Neda, et al.
Publicado: (2022)

Hypothyroidism and diabetes mellitus – a risky dual gestational endocrinopathy
por: Tirosh, Dan, et al.
Publicado: (2013)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
por: Singeap, Ana-Maria, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Association of sex hormones and sex hormone-binding globulin with liver fat in men and women: an observational and Mendelian randomization study
por: Cai, Xinting, et al.
Publicado: (2023)

Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial
por: Tutunchi, Helda, et al.
Publicado: (2020)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
por: Naeini, Fatemeh, et al.
Publicado: (2021)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Fetal hormonal programming of sex differences in depression: linking women's mental health with sex differences in the brain across the lifespan
por: Goldstein, Jill M., et al.
Publicado: (2014)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Interactive effects of culture and sex hormones on the sex role self-concept
por: Pletzer, Belinda, et al.
Publicado: (2015)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Sphingosine 1- Phosphate Lyase Insufficiency Syndrome (SPLIS); A Role in Multiple Endocrinopathies
por: Wai Kwong, Ruth Ming, et al.
Publicado: (2021)

TAFRO Syndrome: A Case of Significant Endocrinopathy in a Caucasian Patient
por: Miatech, Jennifer L, et al.
Publicado: (2019)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease
por: Fröhlich, Eleonore, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8654cs47o6usgmifpi6fmdukb1